Delivery Order SPE2DB20D1047-SPE2DB25FF83M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $63,839.13 under a firm fixed price contract. This delivery order represents a competitive award with no set-aside designation and is expected to be completed by September 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $7,690.32 to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,424.26. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025, utilizing firm fixed price pricing. This is a non-set-aside competitive award, and the place of performance is listed as Conshohocken, Pennsylvania, which is also the company's corporate headquarters location. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $3,962.99 and an ultimate completion date of September 10, 2025. Euflexxa is a viscosupplement injection used to treat knee osteoarthritis pain. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes with a ceiling value of $6,754.59 on August 14, 2025. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and no set-aside designation was used. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The award has a ceiling value of $6,113.56 and an ultimate completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and...
- The Defense Logistics Agency awarded a $23.6K delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 MG/2 ML syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA, leveraging the company's position as a critical distributor of medical products for federal healthcare systems. The award carries no...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,474.82 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a completion date of September 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $3,090.60 and is a firm fixed-price delivery order with a completion date of July 7, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The potential value of this delivery order is $3,485.16, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is part of a larger indefinite delivery contract...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF83MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,454.88 under a firm fixed-price contract. This delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The award was competitively awarded without set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medical products to military and veteran healthcare systems, including specialty medications, vaccines, and medical devices. The IDC serves as a flexible contract vehicle enabling the company to fulfill pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/11/25 |